Silencing IDO1 inhibited tumor cell growth by upregulating p53, coupled with increases in p53 upregulated modulator of apoptosis (PUMA) and Bax in B-cell lymphoma [31]. This evidence concerns the gene BBC3 and B-cell non-Hodgkin lymphoma.